tiprankstipranks

Philip Tsai Insider Profile

11 Followers
Philip Tsai, CTO at Immunome, holds 81.55K shares in Immunome (Ticker: IMNM).
tipranks
Philip Tsai

Philip Tsai
Immunome (IMNM)
CTO

Ranked #11,386 out of 108,921 Corporate Insiders

Profitable Transactions

100%
3 out of 3 Profitable Transactions

Average Return

+92.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Philip Tsai's holdings

Insider Roles

Immunome
(IMNM)
CTO
Roles that Philip Tsai holds in companies

Most Profitable Insider Trade

Stock:
Immunome
(IMNM)
Rating:Informative Buy
Date:Mar 25, 2025 - Mar 25, 2026
Return:+192.00%
The most profitable trade made by Philip Tsai

Philip Tsai's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Immunome
Jul 27, 2026
CTO
Uninformative Buy
$2.13M
Success Rate for
IMNM
3 out of 3 profitable transactions on
IMNM
100%
Average Return for
IMNM
Average return per transaction on
IMNM
+92.50%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 25, 2024
Informative Buy
$198.03K
21,000
$9.43
+64.10%
Mar 25, 2025
Informative Buy
$103.57K
12,300
$8.42
+192.00%
Dec 22, 2025
Informative Buy
$204.90K
10,000
$20.49
+21.40%
Jul 27, 2026
Uninformative Buy
$0.00
38,250
$0.00
List of latest transactions for each holding click on a transaction to see Philip Tsai's performance on stock

Philip Tsai insider profile FAQ

What is the percentage of profitable transactions made by Philip Tsai?
The percentage of profitable transactions made by Philip Tsai is 100%.
    What is the average return per transaction made by Philip Tsai?
    The average return per transaction made by Philip Tsai is 92.50%.
      What stocks does Philip Tsai hold?
      Philip Tsai holds: IMNM stocks.
        What was Philip Tsai’s latest transaction?
        Philip Tsai latest transaction was an Uninformative Buy of ―.
          What was Philip Tsai's most profitable transaction?
          Philip Tsai’s most profitable transaction was an Informative Buy of IMNM stock on March 25, 2025. The return on the trade was 192.00%.
            What is Philip Tsai's role in Immunome?
            Philip Tsai's role in Immunome is CTO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.